144 related articles for article (PubMed ID: 21843522)
1. Tumor-induced osteomalacia: The tumor may stay hidden!
van der Rest C; Cavalier E; Kaux JF; Krzesinski JM; Hustinx R; Reginster JY; Delanaye P
Clin Biochem; 2011 Oct; 44(14-15):1264-6. PubMed ID: 21843522
[TBL] [Abstract][Full Text] [Related]
2. [Hypophosphatemia and tumor-induced osteomalacia].
van der Rest C; Cavalier E; Colson L; Kaux JF; Krzesinski JM; Reginster JY; Hustinx R; Delanaye P
Rev Med Suisse; 2011 Aug; 7(306):1630-3. PubMed ID: 21972729
[TBL] [Abstract][Full Text] [Related]
3. Cinacalcet in the management of tumor-induced osteomalacia.
Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced osteomalacia originating from the temporal bone: a case report.
Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced osteomalacia: a case of diagnostic dilemma.
Robertson A; Mansberg R; Mansberg V; Van der Wall H; Hooper M
Clin Nucl Med; 2007 Aug; 32(8):631-4. PubMed ID: 17667438
[TBL] [Abstract][Full Text] [Related]
6. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
Westerberg PA; Linde T; Ljunggren O
Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
[No Abstract] [Full Text] [Related]
7. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
8. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced osteomalacia: lessons learned.
Lewiecki EM; Urig EJ; Williams RC
Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
[TBL] [Abstract][Full Text] [Related]
10. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
12. The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.
Ishii A; Imanishi Y; Kobayashi K; Hashimoto J; Ueda T; Miyauchi A; Koyano HM; Kaji H; Saito T; Oba K; Komatsu Y; Kurajoh M; Nagata Y; Goto H; Wakasa K; Sugimoto T; Miki T; Inaba M; Nishizawa Y
Calcif Tissue Int; 2010 Jun; 86(6):455-62. PubMed ID: 20458578
[TBL] [Abstract][Full Text] [Related]
13. A case report of tumor-induced osteomalacia: eight year followed-up.
Ratanasuwan T; Chetsurakarn S; Ongphiphadhanakul B; Damrongkitchaiporn S
J Med Assoc Thai; 2008 Dec; 91(12):1900-2. PubMed ID: 19133527
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatemic osteomalacia as a long-term complication after liver transplantation.
Kawate H; Taketomi A; Watanabe T; Nomura M; Kato M; Sakamoto R; Ikegami T; Soejima Y; Maehara Y; Takayanagi R
Transplantation; 2011 Jan; 91(1):e6-8. PubMed ID: 21441849
[No Abstract] [Full Text] [Related]
15. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset vitamin-D-resistant hypophosphatemic osteomalacia. Effect of total parathyroidectomy.
Riggs BL; Sprague RG; Jowsey J; Maher FT
N Engl J Med; 1969 Oct; 281(14):762-6. PubMed ID: 5807923
[No Abstract] [Full Text] [Related]
17. [Tumor-induced hypophosphatemic osteomalacia].
Ito N; Fukukmoto S
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
[No Abstract] [Full Text] [Related]
18. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case.
Dupond JL; Mahammedi H; PriƩ D; Collin F; Gil H; Blagosklonov O; Ricbourg B; Meaux-Ruault N; Kantelip B
Bone; 2005 Mar; 36(3):375-8. PubMed ID: 15777669
[TBL] [Abstract][Full Text] [Related]
19. A paranasal tumor associated with tumor-induced osteomalacia.
Inokuchi G; Tanimoto H; Ishida H; Sugimoto T; Yamauchi M; Miyauchi A; Nibu K
Laryngoscope; 2006 Oct; 116(10):1930-3. PubMed ID: 17003734
[TBL] [Abstract][Full Text] [Related]
20. Acquired osteomalacia.
Bell NH; Key LL
Curr Ther Endocrinol Metab; 1994; 5():495-9. PubMed ID: 7704780
[No Abstract] [Full Text] [Related]
[Next] [New Search]